GLYCOSYN
Live / Registered — Registered and renewed (as of 18 Sept 2023)
What this means for you
Registered since 09 Apr 2013. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 09 Apr 2023).
Record
- Serial number
- 85441411
- Registration number
- 4315578
- Mark type
- Stylized text
- Filed
- 06 Oct 2011
- Published for opposition
- 18 Sept 2012
- Registered
- 09 Apr 2013
- Next maintenance due
- 09 Apr 2023
- Attorney of record
- Kevin S. Costanza
Goods and services
- Class 001 — Chemicals: Carbohydrate-derived chemicals and peptides for use in industry; chemical additives for use in the manufacture of pharmaceuticals and cosmetics
- Class 005 — Pharmaceuticals: Active pharmaceutical ingredients sold as an integral component of pharmaceutical preparations for the treatment of pain, inflammation, infection, diabetes, cancers and for wound repair; pharmaceutical ingredients used in enzyme replacement therapies, therapeutic vaccines (adjuvants), stem cell therapies, and for enhanced drug delivery; antioxidants; vaccines for the treatment of cancer; adjuvants and antigens for vaccines; active veterinary ingredients sold as an integral component of veterinary preparations for the treatment of bloat and for improving fecundity; herbicides and pesticides for commercial, agricultural or industrial use
- Class 042 — Scientific and technological services: Scientific and technological research services in the fields of biotechnology, carbohydrate chemistry and pharmaceuticals including research services in the field of pharmaceutical and drug manufacture; biological, pharmaceutical and medical research; testing services, namely, testing, inspection or research of pharmaceuticals and drugs; laboratory services, namely, chemical synthesis of active pharmaceutical intermediates (APIs) for use in pre-clinical and human clinical trials; pharmaceutical research and development services, namely, active pharmaceutical intermediates (APIs) research and development to support pre-clinical and early phase human clinical trials; chemical laboratory analytical services, namely, analyzing pharmaceuticals and potential pharmaceutical ingredients
Owner
- CALLAGHAN INNOVATION, LOWER HUTT, NZ
- Industrial Research Limited, Lower Hutt, NZ
- Industrial Research Limited, Lower Hutt, NZ
- Industrial Research Limited, Lower Hutt, NZ
Prosecution history
- 18 Sept 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 18 Sept 2023 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 18 Sept 2023 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 18 Sept 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 10 Mar 2023 — TEAS SECTION 8 & 9 RECEIVED
- 09 Apr 2022 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 21 May 2019 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 21 May 2019 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 21 May 2019 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 09 Apr 2019 — TEAS SECTION 8 & 15 RECEIVED
- 09 Apr 2018 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 05 Aug 2015 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 09 Apr 2013 — REGISTERED-PRINCIPAL REGISTER
- 14 Jan 2013 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 07 Jan 2013 — NOTICE OF ALLOWANCE CANCELLED